Literature DB >> 23657380

China overhauls drug regulation agency.

Hepeng Jia.   

Abstract

Mesh：

Year:  2013        PMID： 23657380     DOI： 10.1038/nbt0513-375

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  China syndrome--a regulatory framework in meltdown?

Authors:  Hepeng Jia
Journal:  Nat Biotechnol       Date:  2007-08-02       Impact factor: 54.908
  1 in total
  1 in total

1.  Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.

Authors:  Yichen Zhang; Huseyin Naci; Anita K Wagner; Ziyue Xu; Yu Yang; Jun Zhu; Jiafu Ji; Luwen Shi; Xiaodong Guan
Journal:  JAMA Netw Open       Date:  2022-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.